Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?
about
The apolipoprotein E gene, attention, and brain functionEffects of chronic stress on memory decline in cognitively normal and mildly impaired older adults.Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E.The effects of cholesterol on learning and memory.Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline.Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.Mild cognitive impairment: historical development and summary of researchApolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general populationVitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adultsBlood pressure interacts with APOE ε4 to predict memory performance in a midlife sample.Prospective Study of Arterial Stiffness and Subsequent Cognitive Decline Among Community-Dwelling Older Japanese.Apolipoprotein E epsilon4 and impaired episodic memory in community-dwelling elderly people: a marked sex difference. The Hordaland Health Study.Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.Investigating cognitive genetics and its implications for the treatment of cognitive deficit.The influence of APOE and TOMM40 polymorphisms on hippocampal volume and episodic memory in old ageSelective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease.Genetic and vascular modifiers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension.APOE polymorphism, socioeconomic status and cognitive function in mid-life--the Whitehall II longitudinal study.1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.The genetics of episodic memory.APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory.Influence of serotonin transporter gene polymorphisms on cognitive decline and cognitive abilities in a nondemented elderly population.Moderate alcohol use and apolipoprotein E-4 (ApoE-4): Independent effects on cognitive outcomes in later life.Motor timing intraindividual variability in amnestic mild cognitive impairment and cognitively intact elders at genetic risk for Alzheimer's disease.Vitamin D Receptor and Megalin Gene Polymorphisms Are Associated with Longitudinal Cognitive Change among African-American Urban Adults.Confirmatory factor analysis of the PTSD checklist in the elderly.Inverse effect of the APOE epsilon4 allele in late- and early-onset Alzheimer's disease.Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study.A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances.Associations of APOE ε4 With Health and Financial Literacy Among Community-Based Older Adults Without Dementia.Performance on neurocognitive tests by co-twins to dementia cases compared to normal control twins.Determinants of a sense of mastery in African American and White older adults.Longitudinal memory performance during normal aging: twin association models of APOE and other Alzheimer candidate genes.Association between apolipoprotein E4 and cognitive decline in elderly adults.Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease.Cross-cultural comparability of the Geriatric Depression Scale: comparison between older Koreans and older Americans.Thinking ahead: factors associated with executing advance directives.Influence and interactions of cathepsin D, HLA-DRB1 and APOE on cognitive abilities in an older non-demented population.Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.
P2860
Q24539024-8B012407-665B-4509-AA9A-37123CCE8AFBQ33827921-872A7C82-7475-4C64-9EE9-F8ECA876D2E9Q33919169-9EF81E15-FE62-499E-8537-891F55736B50Q33976829-AA485020-3549-452E-86B3-03425C184122Q34013606-F17BEFC2-41A2-4690-BC6E-41285BA001C5Q34284146-84FD57DB-822F-4621-8A7F-9EA81EDCB2BDQ34570703-0A2F8450-AC15-41B5-8B4E-A222F34C7929Q35236843-2BC867BB-863F-46E3-9DC5-46078863DCD0Q35440542-9B98C391-5221-4A06-99ED-88452C3236D2Q35615257-4B64C7BC-5A4A-42DC-ABA0-93B708739EF0Q35995579-88FEB251-FA89-42C9-831E-782D37ADD629Q35996305-94DEF72A-A5A6-4D0E-BF4E-DFD1447D3588Q36142719-9DB1DF17-F10A-4054-8D32-B4A9048D6E4FQ36240571-FF1F5CFD-EE49-47DE-B072-75AC8FDA8B1AQ36370676-140601FB-29F2-4BA5-BD5C-786A23E1E3C0Q36864568-9B236A98-98A6-47D4-8F0B-A0E240480F19Q36934201-44AB7191-957D-42A3-ADD7-E21FD07F3A8DQ37311508-544344FF-A3EB-4664-9F8F-767C4907E215Q37338819-0C4609E3-5282-4EC7-95C2-6135267E601DQ37398623-C1EBFF7A-D321-46D1-A0BF-A26C1A8B77B3Q37563071-1EE4F6D0-5FAC-4F3A-ADC4-FEBE34D9B769Q37623222-9429E209-65C3-49C3-AF1A-CAC161E9165FQ38413138-7598E846-2AB2-4196-B843-D053355D321BQ38665508-C3EBB0AE-AA5D-4769-A145-B144B708C69EQ38774831-EDD47461-1F2B-4523-9E0E-4F4D51183BA9Q38818022-FDDEECB6-6E45-4F45-9DDF-D6C098F11C40Q39098255-BD1B6E9B-DA85-4222-8213-EBD79FC2CCE5Q41012770-A3921DEB-DF42-4030-9D64-FA3ACFC3B3F4Q43289323-8239DBFF-9006-46DF-84D4-B0E41E004255Q43882794-E19A160A-0AD9-47CD-A074-C785B41EB32DQ44239855-3688F271-1B98-43C0-BD1D-9A3C554C4376Q45988698-109E471B-8DCC-4BFB-A691-66AD04BC4DCEQ46147538-213FA27E-09A7-4A11-ADE1-33394FB4C4B8Q46594466-D8D45AF6-2743-4F80-95B6-8C6A2B8DD21CQ46916876-23C2EB94-2F05-49D3-98EE-CDB01145A90BQ47593264-0B9D5752-640C-4E48-8D45-05ACDA3201C3Q47612915-FFE55D44-8030-4858-9CC4-A90E623B4A5CQ47850038-9E6621BC-33ED-4DD2-8997-26C24C0852B7Q48685422-B819FEB8-35AD-46B9-9C2B-68D3415C095CQ48756217-49D9FC2D-2431-4361-98B9-5BC5AFD84845
P2860
Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?
@en
Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?
@nl
type
label
Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?
@en
Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?
@nl
prefLabel
Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?
@en
Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?
@nl
P2093
P356
P1433
P1476
Is APOE--epsilon4 a risk factor for cognitive impairment in normal aging?
@en
P2093
P304
P356
10.1212/WNL.54.11.2082
P407
P577
2000-06-01T00:00:00Z